Staphylococcal Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Publisher Name :
Date: 01-Nov-2016
No. of pages: 100
This report is available at upto 40% Discount. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's Report, "Staphylococcal Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Staphylococcal Infections Report is to understand the market and pipeline status of the drugs around the Staphylococcal Infections to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Staphylococcal Infections. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight's report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Scope:

- A snapshot of the global Market and Phase III therapeutics scenario for Staphylococcal Infections.

- A review of the marketed products under prescription for Staphylococcal Infections, regulatory information and marketing status.

- Coverage of global patent coverage and detailed commentaries on the US patent challenges.

- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

- Product profiles for marketed products for Staphylococcal Infections with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

- Coverage of API Manufacturers for Staphylococcal Infections drugs in the United States, Europe and Asian Regions with location details.

- Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Staphylococcal Infections drugs.

- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Staphylococcal Infections drugs.

- Coverage of Staphylococcal Infections Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.

- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.

- Key discontinued Marketed products.

- Global Sales Figure to 2018.

Reasons to buy

- Evaluate the marketing status and exclusivity details of Staphylococcal Infections key products to exploit opportunities for generic drug development opportunities.

- Identify and understand important and diverse types of therapeutics under Phase III development for Staphylococcal Infections.

- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Staphylococcal Infections.

- API intelligence over marketed drugs for Staphylococcal Infections and gaining primary intelligence over active ingredients manufacturers across the globe.

- API intelligence over leading Phase III Pipeline drugs.

- Develop and design strategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.

- Understanding the scope of the Phase III Drugs with nil regulatory filings.

- Understanding the chemical route of synthesis of approved drugs for Staphylococcal Infections.

- Uncovering opportunities in the rapidly growing US market.

Staphylococcal Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Table of Contents

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Staphylococcal Infections
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Staphylococcal Infections
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Staphylococcal Infections
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables

Staphylococcal Infections Therapeutic Market, US, Marketed Drugs by Application Type, 2016
Staphylococcal Infections Therapeutic Market, US, Marketed Drugs by Marketing Status, 2016
Staphylococcal Infections Therapeutic Market, US, (Year), 2016
Staphylococcal Infections Marketed Drugs, API Manufacturers by US DMF Status, 2016
Staphylococcal Infections Marketed Drugs, US DMF Status Drug Specific (Number), 2016
Staphylococcal Infections Drugs, API Manufacturers, Europe by Country, 2016
Staphylococcal Infections Drugs, API Manufacturers, India by State, 2016
Staphylococcal Infections Drugs, API Manufacturers, China by Province, 2016
Staphylococcal Infections Drugs, API Manufacturers by Geography 2016
Staphylococcal Infections Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2016
Staphylococcal Infections Therapeutic Market, Global Sales-2018 (in million USD)
API Manufacturers for Drug, 2016
Phase III Drugs for Staphylococcal Infections, 2016
Discontinued Drugs for Staphylococcal Infections, 2016

List of Figures

Staphylococcal Infections Therapeutic Market, US, Marketed Drugs by Application Type (%), 2016
Staphylococcal Infections Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2016
Staphylococcal Infections Therapeutic Market, US, (Year), 2016
Staphylococcal Infections Marketed Drugs, API Manufacturers by US DMF Status (%), 2016
Staphylococcal Infections Marketed Drugs, US DMF Status Drug Specific (Number), 2016
Staphylococcal Infections Drugs, API Manufacturers, Europe by Country, 2016
Staphylococcal Infections Drugs, API Manufacturers, India by State, 2016
Staphylococcal Infections Drugs, API Manufacturers, China by Province, 2016
Staphylococcal Infections Drugs, API Manufacturers by Geography 2016
Staphylococcal Infections Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2016
Staphylococcal Infections Therapeutic Market, Global Sales 2018 (in million USD)
Drug, Patent/Exclusivity Expiry (Year), 2016
  • Pseudomonas aeruginosa Infections - Pipeline Review, H2 2016
    Published: 07-Dec-2016        Price: US 2000 Onwards        Pages: 250
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pseudomonas aeruginosa Infections - Pipeline Review, H2 2016, provides an overview of the Pseudomonas aeruginosa Infections (Infectious Disease) pipeline landscape.Pseudomonas aeruginosa has become an important cause of infection, especially in patients with compromised host defense mechanisms. It is the most common pathogen isolated from patients who have been hospitalized for more than one week. Signs and sy......
  • Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections - Pipeline Review, H2 2016
    Published: 07-Dec-2016        Price: US 2000 Onwards        Pages: 45
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections - Pipeline Review, H2 2016, provides an overview of the Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections (Infectious Disease) pipeline landscape.MRSA infections that are acquired by persons who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialy......
  • Europe Ganciclovir Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Ganciclovir Revenue, means the sales value of Ganciclovir This report studies sales (consumption) of Ganciclovir in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Roche - Bausch & Lomb - Fresenius Kabi - Luitpold - Huatai Pha......
  • Global Meningococcal Infections Vaccine Market Professional Survey Report 2016
    Published: 05-Dec-2016        Price: US 3500 Onwards        Pages: 106
    Notes: Production, means the output of Meningococcal Infections Vaccine Revenue, means the sales value of Meningococcal Infections Vaccine This report studies Meningococcal Infections Vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global ma......
  • Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Sales Market Report 2016
    Published: 05-Dec-2016        Price: US 4000 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Revenue, means the sales value of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections This report studies sales (consumption) of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for ......
  • Impetigo - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 45
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Impetigo - Pipeline Review, H2 2016, provides an overview of the Impetigo (Infectious Disease) pipeline landscape.Impetigo is a highly contagious skin condition. Impetigo is caused by two bacteria streptococcus pyogenes and staphylococcus aureus. Symptoms include fluid-filled blisters, itchy rash, skin lesions and swollen lymph nodes. Risk factors include skin-to-skin contact, injury to the skin, having diabet......
  • Q Fever - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 41
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Q Fever - Pipeline Review, H2 2016, provides an overview of the Q Fever (Infectious Disease) pipeline landscape.Q fever, also called query fever, is a bacterial infection caused by the bacteria Coxiella burnetii. Common symptoms of Q fever include high fever, cough, headache, diarrhea, nausea, abdominal pain, jaundice and muscle pain. Risk factors include occupations. Treatment includes antibiotics.......
  • Hepatitis B - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 389
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis B - Pipeline Review, H2 2016, provides an overview of the Hepatitis B (Infectious Disease) pipeline landscape.Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus. Hepatitis B virus can cause an acute illness with symptoms that last several weeks, including yellowing of the skin and eyes (jaundice), dark urine, extreme fatigue, nausea, vomiting and abdominal p......
  • Hand, Foot and Mouth Disease - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 36
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hand, Foot and Mouth Disease - Pipeline Review, H2 2016, provides an overview of the Hand, Foot and Mouth Disease (Infectious Disease) pipeline landscape.Hand, foot and mouth disease is an illness that causes sores in or on the mouth and on the hands, feet, and legs. Hand, foot and mouth disease (HFMD) is most commonly caused by coxsackievirus A16, a member of the enterovirus family. Symptoms include fever, he......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs